EXEL vs UNH: fair value comparison
Exelixis, Inc. and UnitedHealth Group Incorporated · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, EXEL currently sits closer to the top of our discount ranking. EXEL carries the stronger quality grade.
| EXEL | UNH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $55.06 | $392.95 |
| 12-month range | $37.18–$55.06 | $273.98–$415.36 |
| Sector rank | #48 of 113 Healthcare | #53 of 113 Healthcare |
| Quality grade | A | F |
| Leverage | Low | Moderate |
| Margin trend | Stable | Contracting |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | Fairly Valued | Undervalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: EXEL fair value analysis · UNH fair value analysis